Wed Feb 6, 2008 6:00 PM
MDG February 2008 Forum: Getting Your Money Out: How to Create Real Value in Your Medical Device Company
Entrepreneurs are usually more concerned about getting funding for their companies and give little thought to getting the money out. Leaders of existing companies often struggle to realize sufficient ROI and capital gain as they try to take their organizations from where they are to a successful exit. It is often much easier to start and run a medical device company than to get out successfully. How do you develop and build a company with a mind towards harvest? What can and should be done, from the start, to ensure a successful exit from your venture in a responsible and financially rewarding way? What are the options? What assets are most sought and liabilities considered a fatal flaw when going through the process?
Venture capitalists and other investors typically have three criteria when deciding whether an opportunity is high-potential: (1) the lead entrepreneur and their team, (2) the potential of the market, and (3) the likelihood of a successful harvest. The ability to harvest separates the successful medical device entrepreneur from the rest. How many stories have you heard about companies that have failed to get the value that they expected? Starting a venture with a mind towards ROI and capital gain is central to success. What can you do to put your company in the best position for a successful exit? What should you know today to create the foundation for a successful, post-venture life tomorrow?
Hear an entrepreneur, an investor and a buyer:
• Describe the initiative or venture they harvested or were part of,
• Help us understand harvest options and why the harvest is important,
• Tell us what strategies work to attract the right buyer,
• Describe how starting with a harvest mind-set influenced their decisions and priorities,
• Outline circumstances that worked in their favor and those that worked against,
• Delineate their lessons learned if they could roll back time.
Moderator:
| Name |
Title/Company |
| John Hession |
Partner in Charge, Cooley Godward Kronish, LLP |
Speakers:
| Name |
Title/Company |
| Robyn C. Davis |
Managing Director, Angel Healthcare Investors, LLC |
| William Edelman |
CEO, TyRx |
| Ben Dunn |
Managing Director, Covington Associates |
Event Co-Champions:
| Name |
Title/Company |
| John Geisel |
Partner, Growth Strategy Partners |
| Howard Perlstein |
Principal, HOW Management |
Registration Fee:
| Members: |
$15 (PrePaid), $25 at the door |
| NonMembers: |
$30 (PrePaid), $35 at the door |
Due to increasing popularity, you are urged to pre-register early. Registration is on a first come, first served basis. Pre-registration closes 12:00 noon on the day of the event (Wednesday) or earlier if room capacity is reached. Otherwise, walk-ins will be welcomed up to room capacity.
Add this event to Outlook